5 completed, 2 withdrawn. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Withdrawn 2 |
| Phase 2 | 2 | Completed 2 |
Follow Modra Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer Docetaxel in Parenteral Dosage Form, ModraDoc006/r - Prostate Cancer Metastatic, Castration-resistant Prostate Cancer | Phase 2 | Completed | Modra Pharmaceuticals | 135 | 2019-07-17 | 2024-04-17 |
| ModraDoc006/r in Patients With Breast Cancer ModraDoc006/r - Metastatic Breast Cancer, Recurrent Breast Cancer | Phase 2 | Completed | Modra Pharmaceuticals | 12 | 2019-01-30 | 2021-10-19 |
| Absorption and Excretion of Oral Docetaxel ModraDoc006/r - Solid Tumor, Adult | Phase 1 | Withdrawn | Modra Pharmaceuticals | 2017-10-01 | 2022-02-16 | |
| Oral Docetaxel in Patients With Normal or Impaired Liver Function ModraDoc006/r - Solid Tumor, Adult, Impaired Liver Function | Phase 1 | Withdrawn | Modra Pharmaceuticals | 2017-07-01 | 2021-10-19 | |
| Food Effect Study of ModraDoc006 in Combination With Ritonavir ModraDoc006/r - Solid Tumor, Adult | Phase 1 | Completed | Modra Pharmaceuticals | 18 | 2017-05-10 | 2021-10-19 |
| Extended Use of ModraDoc006/r ModraDoc006/r - Advanced Solid Tumours | Phase 1 | Completed | Modra Pharmaceuticals | 17 | 2017-05-10 | 2021-10-19 |
| ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer ModraDoc006/r - Castration-resistant Prostate Cancer | Phase 1 | Completed | Modra Pharmaceuticals | 23 | 2017-04-26 | 2021-10-19 |
Breast Neoplasms (1) · Liver Diseases (1)
Docetaxel (1) · Injections (1)
Netherlands (5) · Belgium (1) · Czechia (1) · Denmark (1) · Germany (1) · Hungary (1) · Poland (1) · Russia (1) · Spain (1) · United States (1)
Serena Marchetti, MD, PhD (2) · Serena Marchetti, MD/PhD (2) · Andre Bergman, MD, PhD (1) · M Keessen, MSc, MBA (1) · Marianne Keessen (1)